Keyphrases
Monoclonal Antibody
100%
Sickle Cell Disease
100%
Cell Depletion
100%
Invariant NKT Cells
100%
Anti-invariant
100%
High Dose
33%
Serious Adverse Events
22%
Vaso-occlusion
22%
Murine Model
11%
Cell Activity
11%
Inflammatory Response
11%
Steady State
11%
Peripheral Blood
11%
Tissue Injury
11%
Plasma Parameters
11%
Limit of Quantification
11%
Pharmacokinetics-pharmacodynamics (PK-PD)
11%
Vaso-occlusive Crisis
11%
Single Ascending Dose
11%
Decrease Rate
11%
State Patient
11%
Medicine and Dentistry
Natural Killer T Cell
100%
Monoclonal Antibody
100%
Sickle-Cell Disease
100%
Drug Megadose
33%
Adverse Event
22%
Serositis
11%
Infusion
11%
Cell Activity
11%
Steady State
11%
Pharmacodynamics
11%
Tissue Injury
11%
Pharmacokinetics
11%
Patient with Sickle Cell Disease
11%
Pharmacology, Toxicology and Pharmaceutical Science
Monoclonal Antibody
100%
Sickle Cell Anemia
100%
Adverse Event
40%
Pharmacodynamics
20%
Inflammation
20%
Tissue Injury
20%
Pharmacokinetics
20%